HWAM
Hennion & Walsh Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.25M | Sell |
122,769
-24,424
| -17% | -$1.24M | 0.25% | 75 |
|
|
2025
Q1 | $6.63M | Buy |
147,193
+1,594
| +1% | +$71.8K | 0.29% | 63 |
|
|
2024
Q4 | $6.02M | Buy |
145,599
+29,545
| +25% | +$1.22M | 0.27% | 76 |
|
|
2024
Q3 | $4.53M | Buy |
116,054
+11,284
| +11% | +$440K | 0.21% | 110 |
|
|
2024
Q2 | $3.58M | Buy |
104,770
+41,236
| +65% | +$1.41M | 0.18% | 134 |
|
|
2024
Q1 | $1.6M | Buy |
63,534
+15,022
| +31% | +$377K | 0.09% | 306 |
|
|
2023
Q4 | $1.43M | Buy |
48,512
+22,019
| +83% | +$650K | 0.08% | 316 |
|
|
2023
Q3 | $837K | Buy |
26,493
+12,516
| +90% | +$396K | 0.05% | 399 |
|
|
2023
Q2 | $362K | Buy |
+13,977
| New | +$362K | 0.02% | 602 |
|